001468526 000__ 04804cam\\22006137i\4500
001468526 001__ 1468526
001468526 003__ OCoLC
001468526 005__ 20230707003255.0
001468526 006__ m\\\\\o\\d\\\\\\\\
001468526 007__ cr\cn\nnnunnun
001468526 008__ 230607s2023\\\\sz\\\\\\ob\\\\001\0\eng\d
001468526 019__ $$a1380686554$$a1381095448
001468526 020__ $$a9783031260780$$q(electronic bk.)
001468526 020__ $$a3031260783$$q(electronic bk.)
001468526 020__ $$z3031260775
001468526 020__ $$z9783031260773
001468526 0247_ $$a10.1007/978-3-031-26078-0$$2doi
001468526 035__ $$aSP(OCoLC)1381337113
001468526 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dYDX$$dEBLCP
001468526 049__ $$aISEA
001468526 050_4 $$aRM267
001468526 08204 $$a615.7/92$$223/eng/20230607
001468526 1001_ $$aFong, I. W.$$q(Ignatius W.),$$eauthor.
001468526 24510 $$aNew antimicrobials :$$bfor the present and the future /$$cI.W. Fong.
001468526 264_1 $$aCham, Switzerland :$$bSpringer,$$c2023.
001468526 300__ $$a1 online resource (192 pages).
001468526 336__ $$atext$$btxt$$2rdacontent
001468526 337__ $$acomputer$$bc$$2rdamedia
001468526 338__ $$aonline resource$$bcr$$2rdacarrier
001468526 4901_ $$aEmerging infectious diseases of the 21st century
001468526 504__ $$aIncludes bibliographical references and index.
001468526 5050_ $$a1. Antimicrobial Resistance: A crisis in the making -- 2: New Cephalosporins: 5th and 6th generations -- 3: New -lactam--lactamase inhibitor combinations -- 4: New Glycopeptides: Televancin, dalbavancin and oritavancin -- 5: A new fluoroquinoloneDelafloxacin -- 6: New Oxazolininone---Tedizolid -- 7: New Tetracyclines: Eravacycline and Omadacycline -- 8: Pleuromutilin: A new class of antibiotic: Lefamulin -- 9: New anti-tuberculous drugs: Bedaquiline, Delamanid and Pretomanid -- 10: New systemic antifungal: Isavuconazole -- 11: Newly approved anti-parasitic drugs for malaria, fascioliasis, onchocerciasis, Chagas disease and African trypanosomiasis -- 12:New antiretroviral agents for HIV infection -- 13: New Antiviral agents for cytomegalovirus diseases -- 14: New antiviral agent for influenza: Baloxavir -- 15: Direct antiviral agents for hepatitis C -- 16: Antiviral drugs for SARS-CoV-2 and COVID-19 -- 17: New promising antimicrobials in development and novel approaches for treatment of infections.
001468526 506__ $$aAccess limited to authorized users.
001468526 520__ $$aThis is a timely and essential companion to the recently published Antimicrobial Resistance in the 21st Century, Second Edition. Antimicrobial resistance is a major threat to global population health, with government reports projecting it could result in over 10 million deaths in the next 35 years. Development of new agents to combat this threat is one of the WHO's top priorities, but in 2017, it conceded that the current drug development pipeline was insufficient to mitigate the threat. This book discusses recent progress and bolster new agent discovery and development, by providing researchers and students who will soon enter the field with a thorough guide to the advancements made in the last decade. Coverage includes new systemic antimicrobials approved since 2010, with detailed analysis of antibiotics, antivirals, antifungals, and antiparasitics, as well as agents in development for future use. Discussion of each drug will include its chemical nature, pharmacology/pharmacokinetics, antimicrobial spectrum, dosage, adverse reactions, drug interactions, microbial resistance, indications, clinical efficacy compared to older agents, and lists of similar agents with cost comparison. This volume is designed for researchers and students of infectious disease and medical microbiology, as well as clinicians in need of a comprehensive guide to newly developed agents.
001468526 588__ $$aDescription based on print version record.
001468526 650_0 $$aAnti-infective agents$$xDevelopment.
001468526 650_0 $$aDrug resistance in microorganisms.
001468526 655_0 $$aElectronic books.
001468526 77608 $$iPrint version:$$aFONG, IGNATIUS.$$tNEW ANTIMICROBIALS.$$d[Place of publication not identified] : SPRINGER INTERNATIONAL PU, 2023$$z3031260775$$w(OCoLC)1362485220
001468526 830_0 $$aEmerging infectious diseases of the 21st century.
001468526 852__ $$bebk
001468526 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-26078-0$$zOnline Access$$91397441.1
001468526 909CO $$ooai:library.usi.edu:1468526$$pGLOBAL_SET
001468526 980__ $$aBIB
001468526 980__ $$aEBOOK
001468526 982__ $$aEbook
001468526 983__ $$aOnline
001468526 994__ $$a92$$bISE